ABSTRACT
Search Strategy
Below is the search strategy utilised in MEDLINE to identify potentially relevant studies. Keywords are listed in regular type and Medical Subject Heading (MESH) terms in bold. NOT 14 Below is the search strategy utilised in Embase to identify potentially relevant studies. Keywords are listed in regular type and Emtree terms in bold.
hepatitis C OR HCV OR

hepatitis C OR HCV OR exp hepatitis C/ OR exp Hepatitis C virus/ 2. HIV OR "human immunodeficiency virus" OR exp Human immunodeficiency virus OR exp Human
immunodeficiency virus infection/ OR exp Human immunodeficiency virus prevalence/ 3. 1 OR 2 4. IDU OR IDUs OR IVDU OR IVDUs OR PWID OR PWIDs 5. substance* OR drug* 6. inject* OR intravenous 7. abuse* OR depend* OR use* OR misus* OR addict* 8. 5 adj3 6 9. 5 adj3 7 10. exp intravenous drug abuse/ 11. 4 OR 8 OR 9 OR 10 12. prevalence OR incidence OR epidemiol* OR survey OR rapid assessment OR situation assessment OR situational assessment OR RAR OR Cohort OR surveillance OR seroprevalence OR seroincidence OR screening OR exp seroepidemiology/ OR exp seroprevalence/ OR exp epidemiology/ OR exp prevalence/ OR exp epidemiological data/ OR exp incidence/ OR exp observational study/ OR exp cohort analysis/ 13. 3 AND 11 AND 12 14. Limit 13: Animals/ NOT (Humans/ AND Animals/) 15. 13 NOT 14 Below is the search strategy utilised in PsycINFO to identify potentially relevant studies. Keywords are listed in regular type and Thesaurus terms in bold. 
HIV OR "human immunodeficiency virus" OR
Data extraction
Data were extracted from included studies by JS using Microsoft Excel, and were checked by another author (HF), with any discrepancies being resolved by a third author (PV). Key characteristics extracted for each study included: study location, design and period; publication year; inclusion and exclusion criteria; recruitment methodology; methods used to assess incident HIV or HCV infection; mean/median duration of follow-up and rate of attrition; background HIV and HCV prevalence; proportion of study participants at baseline who were recent injectors, female, currently or recently homeless, and had recent or past incarceration; mean age and duration of injecting; population opiate substitution therapy (OST) coverage; number of incident infections and total follow-up time, both stratified by incarceration history (either recent or past); unadjusted and adjusted measures of effect with 95% confidence intervals. visit; sharing needles during the 6 months before visit; participated in methadone maintenance during the 6 months before visit. Clients of the low-threshold facilities were used as seeds for snowball sampling. Injection drug use in the last 12 months, age>=15. Excluded for previous participation in study, and/or current participation in an abstinence-oriented or substitution treatment program, and/or an inability to understand the questions/instructions. 
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